Related Topics News -

     
 Detail   |   Print 
     
《大行》大摩:上海醫藥首季業績符預期
2026-05-05T  
《大行》高盛升上海醫藥目標價至10.63元 維持「沽售」評級
2026-05-05T  
美國會提案禁採納中國臨床數據
2026-05-04T  
《業績》上海醫藥首季歸屬淨利潤按年增長6.35%
2026-04-29T  
上海醫藥潑尼松龍片通過仿製藥一致性評價
2026-04-27T  
《大行》大摩降上海醫藥目標價至15.8元 評級「增持」
2026-04-24T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.